Home
About
Overview
Sharing Data
ORCID
Help
History (25)
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma.
Transient Otoacoustic Emissions and Auditory Brainstem Responses in Low-Risk Cohort of Newborn and One-Month-Old Infants: Assessment of Infant Auditory System Physiology in the Prenatal Alcohol in SIDS and Stillbirth Network Safe Passage Study.
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
Overcoming barriers to biosimilars in inflammatory arthritis.
See All 25 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Overcoming barriers to biosimilars in inflammatory arthritis.
Kay J. Overcoming barriers to biosimilars in inflammatory arthritis. Nat Rev Rheumatol. 2020 Feb; 16(2):65-66.
View in:
PubMed
subject areas
Arthritis
Biosimilar Pharmaceuticals
Cost-Benefit Analysis
European Union
Humans
Legislation, Drug
Observational Studies as Topic
Randomized Controlled Trials as Topic
Treatment Outcome
authors with profiles
Jonathan Kay MD